Cargando…
On high‐risk, low‐grade glioma: What distinguishes high from low?
The distinction between high‐risk and low‐risk patients with low‐grade glioma is far from clear. yet this criterion is used to select patients for immediate postsurgery radiotherapy and chemotherapy.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587541/ https://www.ncbi.nlm.nih.gov/pubmed/30512190 http://dx.doi.org/10.1002/cncr.31834 |
| _version_ | 1783429089270431744 |
|---|---|
| author | Geurts, Marjolein van den Bent, Martin J. |
| author_facet | Geurts, Marjolein van den Bent, Martin J. |
| author_sort | Geurts, Marjolein |
| collection | PubMed |
| description | The distinction between high‐risk and low‐risk patients with low‐grade glioma is far from clear. yet this criterion is used to select patients for immediate postsurgery radiotherapy and chemotherapy. |
| format | Online Article Text |
| id | pubmed-6587541 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65875412019-07-02 On high‐risk, low‐grade glioma: What distinguishes high from low? Geurts, Marjolein van den Bent, Martin J. Cancer Cancer Case Conundrums The distinction between high‐risk and low‐risk patients with low‐grade glioma is far from clear. yet this criterion is used to select patients for immediate postsurgery radiotherapy and chemotherapy. John Wiley and Sons Inc. 2018-12-04 2019-01-15 /pmc/articles/PMC6587541/ /pubmed/30512190 http://dx.doi.org/10.1002/cncr.31834 Text en © 2018 The Authors Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Cancer Case Conundrums Geurts, Marjolein van den Bent, Martin J. On high‐risk, low‐grade glioma: What distinguishes high from low? |
| title | On high‐risk, low‐grade glioma: What distinguishes high from low? |
| title_full | On high‐risk, low‐grade glioma: What distinguishes high from low? |
| title_fullStr | On high‐risk, low‐grade glioma: What distinguishes high from low? |
| title_full_unstemmed | On high‐risk, low‐grade glioma: What distinguishes high from low? |
| title_short | On high‐risk, low‐grade glioma: What distinguishes high from low? |
| title_sort | on high‐risk, low‐grade glioma: what distinguishes high from low? |
| topic | Cancer Case Conundrums |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587541/ https://www.ncbi.nlm.nih.gov/pubmed/30512190 http://dx.doi.org/10.1002/cncr.31834 |
| work_keys_str_mv | AT geurtsmarjolein onhighrisklowgradegliomawhatdistinguisheshighfromlow AT vandenbentmartinj onhighrisklowgradegliomawhatdistinguisheshighfromlow |